VIM and cancer: ATMSC which uptook either nEV (nEV-ATMSC) or MpEV (MpEV-ATMSC) showed no significant changes in the expression of cancer-associated fibroblast markers (e.g., FAP, FSP, Vimentin) (Figure 1E).